Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | -6.35% | -11.06% | +29.20% |
Financials (USD)
Sales 2022 | 2.38M | Sales 2023 | - | Capitalization | 10.25M |
---|---|---|---|---|---|
Net income 2022 | -50M | Net income 2023 | -65M | EV / Sales 2022 | 21.8 x |
Net cash position 2022 | 5.73M | Net Debt 2023 | 13.17M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.14
x | P/E ratio 2023 |
-0.11
x | Employees | 26 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.82% |
Latest transcript on iBio, Inc.
1 day | -6.35% | ||
1 week | -11.06% | ||
Current month | -56.40% | ||
1 month | +68.57% | ||
3 months | +63.89% | ||
6 months | -74.27% | ||
Current year | +29.20% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Brenner
CEO | Chief Executive Officer | 54 | 21-01-17 |
Felipe Duran
DFI | Director of Finance/CFO | 45 | 21-03-31 |
Phan Dillon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chip Clark
CHM | Chairman | 56 | 21-08-22 |
Linda Armstrong
BRD | Director/Board Member | 61 | 20-10-13 |
Gary Sender
BRD | Director/Board Member | 62 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.77 | -6.35% | 180,508 |
24-04-17 | 1.89 | -3.08% | 270,139 |
24-04-16 | 1.95 | +1.04% | 181,102 |
24-04-15 | 1.93 | -4.46% | 208,621 |
24-04-12 | 2.02 | +1.51% | 378,539 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+29.20% | 15.24M | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- IBIO Stock